510(k) Report

510(k) · Cleared

Recalled · Class II · 2019

Emerge PTCA Dilatation Catheter

K163174510(k) SpecialCleared Dec 14, 201630-day reviewClass II21 CFR 870.5100Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Boston Scientific Corporation · LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous

Cleared on Dec 14, 2016 as substantially equivalent to K113220 (Boston Scientific Corporation, 2012) and 2 other predicates after a 30-day review. Its family tree reaches back 4 generations to 1986. 2 later devices descend from it. It has been recalled once.

Decided
Dec 14, 2016
Review
30 days
Class
Class II
Product code
LOX
Recalls
1
Predicates
3

Its longest line of descent runs back 4 generations to P860019 (1986). 2 later devices descend from it, 2 citing it directly.

  1. Root · 4 generations backP860019 Scimed Ptca Dilatation CatheterScimed Life Systems, Inc. · 1986 · Recalled
  2. 3 generations backK113220 Emerge Ptca Dilatation Catheter (Monorail) Emerge Ptca Dilatation…Boston Scientific Corporation · 2012 · Recalled
  3. 2 generations backK121196 Emerge Ptca Dilatation Catheter (Monorail) Emerge Ptca Dilatation…Boston Scientific Corp · 2012 · Recalled
  4. 1 generation backK130391 Emerge Monorail Ptca Dilatation Catheter, Emerge Push Monorail Ptca…Boston Scientific Corp · 2013 · Recalled
  5. This deviceK163174 Emerge PTCA Dilatation CatheterBoston Scientific Corporation · 2016
  6. Descendant · cites it directly · 0 of its ownK223022 SC HONKYTONK PTCA Balloon Dilatation CatheterSino Medical Sciences Technology, Inc. · 2023
  7. Descendant · cites it directly · 0 of its ownK220629 Emerge Monorail PTCA Dilatation CatheterBoston Scientific · 2022

Most influential descendants

Showing 2 of 2 · See all
  • K223022SC HONKYTONK PTCA Balloon Dilatation CatheterSino Medical Sciences Technology, Inc. · 2023 · cites it directly0descendants
  • K220629Emerge Monorail PTCA Dilatation CatheterBoston Scientific · 2022 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4P860019Scimed Ptca Dilatation CatheterScimed Life Systems, Inc.19865
−3K113220Emerge Ptca Dilatation Catheter (Monorail) Emerge Ptca Dilatation Catheter…Boston Scientific Corporation20121
−2K121196Emerge Ptca Dilatation Catheter (Monorail) Emerge Ptca Dilatation Catheter…Boston Scientific Corp20121
−1K130391Emerge Monorail Ptca Dilatation Catheter, Emerge Push Monorail Ptca Dilatation…Boston Scientific Corp20131
0 (this device)K163174Emerge PTCA Dilatation CatheterBoston Scientific Corporation2016—
+1K223022SC HONKYTONK PTCA Balloon Dilatation CatheterSino Medical Sciences Technology, Inc.2023—
+1K220629Emerge Monorail PTCA Dilatation CatheterBoston Scientific2022—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202210
202310
FIG. 1 — Lineage of K163174, 1986–2023Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LOX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LOX device

  1. #1 K254022 FLASH Flex™ Aorto-Ostial Angioplasty Systemscore 12.3 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113220Emerge Ptca Dilatation Catheter (Monorail) Emerge Ptca Dilatation Catheter (Over-the-Wire)
Summary page 6
…== Page 6 === K163174 Predicate Devices EmergeTM PTCA Dilatation Catheter, K113220, cleared 22 March 2012. EmergeTM PTCA Dilatation Catheter, K121196, cleared 3…
Boston Scientific Corporation20121
*K121196Emerge Ptca Dilatation Catheter (Monorail) Emerge Ptca Dilatation Catheter (Over-the-Wire)
Summary page 6
…Devices EmergeTM PTCA Dilatation Catheter, K113220, cleared 22 March 2012. EmergeTM PTCA Dilatation Catheter, K121196, cleared 31 August 2012. EmergeTM PTCA Dilatation Catheter, K130391, cleared…
Boston Scientific Corp20121
*K130391Emerge Monorail Ptca Dilatation Catheter, Emerge Push Monorail Ptca Dilatation Catheter…
Summary page 6
…EmergeTM PTCA Dilatation Catheter, K121196, cleared 31 August 2012. EmergeTM PTCA Dilatation Catheter, K130391, cleared 10 July 2013. Reference NC Emerge™ PTCA Dilatation Catheter, K141236, Device…
Boston Scientific Corp20131
†K141236NC Emerge Ptca Dilatation Catheter (Monorail), NC Emerge Ptca Dilatation Catheter…Boston Scientific Corporation20141

Also cleared against K113220: 5 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K223022SC HONKYTONK PTCA Balloon Dilatation CatheterSino Medical Sciences Technology, Inc.20230
K220629Emerge Monorail PTCA Dilatation CatheterBoston Scientific20220

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 24, 2019Class IIZ-0577-2020Process controlCertain dilation and extension catheters are being recalled because these catheters may have missed the hydrophilic coating step, which creates a lubricious surface on the devices, during the manufacturing process.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 30 years and passes through 3 companies; a new generation was cleared every 3.4 years on median.
  • 4 of the 4 ancestors have a recall of any class.
  • Of its descendants, K223022 (Sino Medical Sciences Technology, Inc., 2023) has gone furthest, with 0 descendants of its own.
  • 5 other devices also cite its predicate K113220.

How does its category compare?

All LOX devices

LOX Catheters, Transluminal Coronary Angioplasty, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · LOX

4in 2024

2007: 192008: 222009: 282010: 322011: 92012: 102013: 62014: 62015: 42016: 92017: 62018: 72019: 12020: 12021: 62022: 52023: 42024: 42026 (partial year): 6
2007high 32 (2010) · low 0 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LOX

241in 2024

2011: 103 days median2012: 120 days median2013: 123 days median2014: 166 days median2015: 119 days median2016: 116 days median2017: 113 days median2018: 80 days median2021: 167 days median2022: 121 days median2023: 138 days median2024: 241 days median2026 (partial year): 156 days median
2007high 241 (2024) · low 80 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LOX

4in 2019

2007: 12008: 802019: 4
2007high 80 (2008) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LOX

1,890in 2025

2007: 1,0532008: 1,0632009: 1,3532010: 1,3922011: 2,0902012: 2,0922013: 2,4362014: 2,3162015: 2,0602016: 2,5782017: 2,7532018: 2,2252019: 2,1022020: 1,9742021: 1,7382022: 1,8162023: 1,7202024: 1,8042025: 1,890
2007high 2,753 (2017) · low 1,053 (2007)2025

MAUDE reports naming product code LOX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200719—11,053
200822—801,063
200928—01,353
201032—01,392
2011910302,090
20121012002,092
2013612302,436
2014616602,316
2015411902,060
2016911602,578
2017611302,753
201878002,225
20191—42,102
20201—01,974
2021616701,738
2022512101,816
2023413801,720
2024424101,804
20250—01,890
202661560—

What is it indicated for?

The Emerge Over-The-Wire and Emerge Monorail PTCA Dilatation Catheters (1.20 mm balloon models) are indicated as pre-dilatation catheters in the stenotic portion of a coronary artery or bypass graft stenosis (≥70% stenosis). The Emerge Over-The-Wire and Emerge Monorail PTCA Dilatation Catheters (balloon models 1.50-4.00 mm) are indicated for the balloon catheter dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the…

Read the full statement (99 words)

The Emerge Over-The-Wire and Emerge Monorail PTCA Dilatation Catheters (1.20 mm balloon models) are indicated as pre-dilatation catheters in the stenotic portion of a coronary artery or bypass graft stenosis (≥70% stenosis).

The Emerge Over-The-Wire and Emerge Monorail PTCA Dilatation Catheters (balloon models 1.50-4.00 mm) are indicated for the balloon catheter dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for the purpose of improving myocardial perfusion.

The Emerge Over-The-Wire and Emerge Monorail PTCA Dilatation Catheters (balloon models 2.00-4.00 mm) are also indicated for the post-delivery expansion of balloon expandable stents (bare metal and drug-eluting).

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K163174: Emerge PTCA Dilatation Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K163174

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026